Cargando…

PD-L1 Expression in Non-Small-Cell Lung Cancer Including Various Adenocarcinoma Subtypes

Purpose: Knowledge regarding programmed death-ligand 1 (PD-L1) expression in lung cancer is limited. We aim to clarify PD-L1-positive expression in non-small-cell lung cancer (NSCLC), including adenocarcinoma subtypes. Methods: In all, 90 NSCLC specimens containing various adenocarcinoma subtypes, i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyazawa, Tomoyuki, Marushima, Hideki, Saji, Hisashi, Kojima, Koji, Hoshikawa, Masahiro, Takagi, Masayuki, Nakamura, Haruhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Editorial Committee of Annals of Thoracic and Cardiovascular Surgery 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388302/ https://www.ncbi.nlm.nih.gov/pubmed/30282880 http://dx.doi.org/10.5761/atcs.oa.18-00163

Ejemplares similares

Different EGFR gene mutations in two patients with synchronous multiple lung cancers: A case report
por: Sakai, Hiroki, et al.
Publicado: (2017)

Pulmonary Hyalinizing Granuloma Mimicking Primary Lung Cancer: An Unusual Case Involving a Pulmonary Tumor
por: Marushima, Hideki, et al.
Publicado: (2020)

Survival significance of epidermal growth factor receptor tyrosine kinase inhibitors and current staging system for survival after recurrence in patients with completely resected lung adenocarcinoma
por: Saji, Hisashi, et al.
Publicado: (2017)

Survival outcomes of adjuvant chemotherapy with modified weekly nab-paclitaxel and carboplatin for completely resected nonsmall cell lung cancer: FAST-nab
por: Marushima, Hideki, et al.
Publicado: (2020)

Solid histological component of adenocarcinoma might play an important role in PD‐L1 expression of lung adenocarcinoma
por: Miyazawa, Tomoyuki, et al.
Publicado: (2021)

Survival significance of coexisting chronic obstructive pulmonary disease in patients with early lung cancer after curative surgery
por: Saji, Hisashi, et al.
Publicado: (2017)

Chronological changes in lung cancer surgery in a single Japanese institution
por: Nakamura, Haruhiko, et al.
Publicado: (2017)

Unusual presentation of pulmonary lymphoepithelioma‐like carcinoma
por: Oi, Ryoko, et al.
Publicado: (2016)

Combining PD-L1 Expression and Standardized Uptake Values in FDG-PET/CT Can Predict Prognosis in Patients With Resectable Non–Small-Cell Lung Cancer
por: Miyazawa, Tomoyuki, et al.
Publicado: (2021)

Identification of key modules and hub genes for small-cell lung carcinoma and large-cell neuroendocrine lung carcinoma by weighted gene co-expression network analysis of clinical tissue-proteomes
por: Nakamura, Haruhiko, et al.
Publicado: (2019)

Thoracic mesenchymal malignant tumors and programed cell death ligand‐1 status: Clinicopathologic and prognostic analysis of eight pulmonary sarcomatoid carcinomas and eight malignant mesotheliomas
por: Otsubo, Kanji, et al.
Publicado: (2021)

A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer
por: Tsunoda, Akihito, et al.
Publicado: (2019)

Successful treatment with nivolumab in a patient with lung adenocarcinoma complicated by pulmonary aspergilloma
por: Furuya, Naoki, et al.
Publicado: (2020)

A solitary pleural metastasis of benign giant cell tumor of bone
por: Mitsui, Ai, et al.
Publicado: (2016)

Protein co-expression network-based profiles revealed from laser-microdissected cancerous cells of lung squamous-cell carcinomas
por: Nishimura, Toshihide, et al.
Publicado: (2021)

Mutant Proteomics of Lung Adenocarcinomas Harboring Different EGFR Mutations
por: Nishimura, Toshihide, et al.
Publicado: (2020)

Disease-related cellular protein networks differentially affected under different EGFR mutations in lung adenocarcinoma
por: Nishimura, Toshihide, et al.
Publicado: (2020)

A quantitative evaluation of the histological type dependence of the programmed death-ligand 1 expression in non-small cell lung cancer including various adenocarcinoma subtypes: a cross-sectional study
por: Kojima, Kensuke, et al.
Publicado: (2021)

A proteogenomic profile of early lung adenocarcinomas by protein co-expression network and genomic alteration analysis
por: Nishimura, Toshihide, et al.
Publicado: (2020)

Cancer stem cell-related marker expression in lung adenocarcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classification
por: Shimada, Yoshihisa, et al.
Publicado: (2013)

Mechanical Study of Various Pedicle Screw Systems including Percutaneous Pedicle Screw in Trauma Treatment
por: Oda, Yoshiaki, et al.
Publicado: (2022)

Scoring of PD-L1 expression intensity on pulmonary adenocarcinomas and the correlations with clinicopathological factors
por: Igarashi, Tomoyuki, et al.
Publicado: (2016)

The Significance of Lactate and Lipid Peaks for Predicting Primary Neuroepithelial Tumor Grade with Proton MR Spectroscopy
por: Nakamura, Hisao, et al.
Publicado: (2017)

Association of histologic subtypes with genetic alteration and PD-L1 expression in pulmonary adenocarcinoma
por: Phruttinarakorn, Bantita, et al.
Publicado: (2020)

Malignant pleural mesothelioma presenting as a spontaneous pneumothorax
por: Mitsui, Ai, et al.
Publicado: (2015)

Histological subtype of gastric adenocarcinoma: two cases of mixed fundic and pyloric mucosa-type adenocarcinoma
por: Takahashi, Haruhiko, et al.
Publicado: (2020)

Targeting BCL2 with venetoclax is a promising therapeutic strategy for “double-proteinexpression” lymphoma with MYC and BCL2 rearrangements
por: Uchida, Akiko, et al.
Publicado: (2019)

Immune profiles according to EGFR mutant subtypes and correlation with PD-1/PD-L1 inhibitor therapies in lung adenocarcinoma
por: Koh, Young Wha, et al.
Publicado: (2023)

Expression of activating natural killer‐cell receptors is a hallmark of the innate‐like T‐cell neoplasm in peripheral T‐cell lymphomas
por: Uemura, Yu, et al.
Publicado: (2018)

Early-stage serrated adenocarcinomas are divided into several molecularly distinct subtypes
por: Hirano, Daiki, et al.
Publicado: (2019)

Various Biomimetics, Including Peptides as Antifungals
por: Efremenko, Elena, et al.
Publicado: (2023)

γH2AX, a DNA Double-Strand Break Marker, Correlates with PD-L1 Expression in Smoking-Related Lung Adenocarcinoma
por: Sakurai, Eiko, et al.
Publicado: (2022)

Consensus Molecular Subtypes Efficiently Classify Gastric Adenocarcinomas and Predict the Response to Anti-PD-1 Immunotherapy
por: Wu, Xiangyan, et al.
Publicado: (2022)

Intracranial Response to Nivolumab in a Patient with PD-L1-negative Lung Adenocarcinoma
por: Nakahara, Yoshiro, et al.
Publicado: (2018)

De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a case report and literature review
por: Uchida, Akiko, et al.
Publicado: (2017)

Figure-4 Patient Positioning Increases Medial Meniscus Extrusion on Ultrasound in Patients With Posterior Medial Meniscus Root Tears of the Knee
por: Hoshikawa, Atsuto, et al.
Publicado: (2023)

Efficacy of combined transbronchial lung cryobiopsy and conventional forceps biopsy for lung malignancies: a prospective cohort study
por: Kinoshita, Kohei, et al.
Publicado: (2023)

Severe tracheal stenosis with tracheopathia osteoplastica-like changes due to traumatic blunt injury
por: Kakinuma, Kazutaka, et al.
Publicado: (2014)

Pre-operative Prediction of Ki-67 Expression in Various Histological Subtypes of Lung Adenocarcinoma Based on CT Radiomic Features
por: Huang, Zhiwei, et al.
Publicado: (2021)

Association of atrial fibrillation and various cancer subtypes
por: Zubair Khan, Muhammad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mo2uas6a7ckineit9rf1s5ssir